Tumor Proteomic Profiling Predicts the Susceptibility of Breast Cancer to Chemotherapy

International Journal of Oncology - Greece
doi 10.3892/ijo_00000380
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Spandidos Publications

Related search

Neutrophil–lymphocyte Ratio Predicts Response to Chemotherapy in Triple-Negative Breast Cancer

Current Oncology
Oncology
2018English

Low Expression of Stathmin in Tumor Predicts High Response to Neoadjuvant Chemotherapy With Docetaxel-Containing Regimens in Locally Advanced Breast Cancer

Genetic Testing and Molecular Biomarkers
MedicineGenetics
2012English

Expression Profiling of Ion Channel Genes Predicts Clinical Outcome in Breast Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2013English

Androgen Receptor Status Predicts Response to Chemotherapy, Not Risk of Breast Cancer in Indian Women

World Journal of Surgical Oncology
SurgeryOncology
2010English

HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy

Frontiers in Immunology
AllergyImmunology
2018English

Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Proteomic Profiling of Lipid Rafts in a Human Breast Cancer Model of Tumorigenic Progression

Clinical and Experimental Metastasis
MedicineCancer ResearchOncology
2011English

P53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2005English

Inferring Predominant Pathways in Cellular Models of Breast Cancer Using Limited Sample Proteomic Profiling

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy